Connor, Clark & Lunn Investment Management (CC&L)
MGNX icon

Connor, Clark & Lunn Investment Management (CC&L)’s MacroGenics MGNX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Buy
1,000,412
+133,163
+15% +$504K 0.01% 757
2026
Q1 		$2.51M Buy
867,249
+48,429
+6% +$103K 0.01% 890
2025
Q4 		$1.32M Buy
818,820
+108,212
+15% +$170K ﹤0.01% 1043
2025
Q3 		$1.19M Buy
710,608
+28,331
+4% +$45.9K ﹤0.01% 1006
2025
Q2 		$826K Sell
682,277
-133,777
-16% -$194K ﹤0.01% 1107
2025
Q1 		$1.04M Buy
816,054
+71,152
+10% +$186K ﹤0.01% 934
2024
Q4 		$2.42M Buy
744,902
+82,988
+13% +$299K 0.01% 672
2024
Q3 		$2.18M Buy
661,914
+186,858
+39% +$728K 0.01% 647
2024
Q2 		$2.02M Buy
475,056
+56,774
+14% +$553K 0.01% 654
2024
Q1 		$6.16M Buy
418,282
+174,086
+71% +$2.63M 0.03% 385
2023
Q4 		$2.35M Buy
244,196
+104,945
+75% +$725K 0.01% 629
2023
Q3 		$649K Buy
+139,251
New +$693K ﹤0.01% 952
2022
Q4 		– Sell
-242,909
Closed -$840K – 1350
2022
Q3 		$840K Buy
242,909
+22,114
+10% +$84.6K 0.01% 694
2022
Q2 		$651K Buy
220,795
+175,342
+386% +$922K ﹤0.01% 717
2022
Q1 		$400K Buy
45,453
+5,657
+14% +$62.4K ﹤0.01% 821
2021
Q4 		$639K Buy
39,796
+3,528
+10% +$66.4K ﹤0.01% 758
2021
Q3 		$759K Buy
+36,268
New +$874K ﹤0.01% 690
2020
Q2 		– Sell
-65,619
Closed -$382K – 1124
2020
Q1 		$382K Buy
65,619
+35,994
+121% +$327K ﹤0.01% 757
2019
Q4 		$322K Buy
+29,625
New +$293K ﹤0.01% 750

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MGNX Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its MacroGenics (MGNX) stake by 15% in Q2 2026, buying an estimated $504K and bringing the position to 1,000,412 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #757.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MGNX in Q4 2019 and has held it in 19 quarters since. The position peaked at $6.16M in Q1 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 1,000,412 shares of MacroGenics worth $4.62M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 133,163 MacroGenics shares in Q2 2026, an estimated $504K.
  • MacroGenics made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #757 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MacroGenics in Q4 2019 and has held it in 19 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s MacroGenics position peaked at $6.16M in Q1 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.